Rayonier Advanced Materials Inc. (RYAM) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a mixed picture. While there are positive aspects like improved margins in Cellulose Specialties and cost reduction initiatives, challenges such as reduced EBITDA guidance, significant declines in Paperboard and High-Yield Pulp EBITDA, and unresolved issues in the Q&A session weigh heavily. The market is likely to react negatively due to the lowered 2025 guidance, operational challenges, and uncertainty in key business areas, despite some optimistic long-term projections.
Key Financial Performance
Revenue $353 million, down $48 million year-over-year. The decrease was attributed to weaker-than-expected results in noncore business segments.
Operating Income $9 million, an improvement of $26 million compared to the prior year. This improvement was driven by higher average selling prices and lower fixed costs.
Adjusted EBITDA $42 million, a $9 million decrease from Q3 2024. The decline was due to weaker results in Paperboard and high-yield pulp segments.
Adjusted Free Cash Flow Negative $83 million year-to-date, driven by working capital timing, which is expected to improve in the fourth quarter.
Cellulose Specialties Net Sales $204 million, down $28 million or 12% from the prior year. The decline was driven by a 17% decrease in sales volumes, partially offset by a 7% increase in average sales prices.
Cellulose Specialties Adjusted EBITDA $66 million compared to $65 million last year, with margins increasing to 32% from 28%. The improvement was driven by higher average selling prices and lower fixed costs.
Biomaterials Net Sales $8 million, flat compared to the prior year. Higher turpentine volumes were offset by lower bioethanol sales volumes caused by temporary feedstock constraints and labor disruptions.
Biomaterials Adjusted EBITDA $1 million compared to $4 million in the prior year, with margins of 13% versus 50% in Q3 of 2024. The decline was due to higher shared and ancillary service costs.
Cellulose Commodities Net Sales $85 million, down $1 million or 1% from the prior year quarter. The decline was due to a 2% decrease in volumes, offset by an 8% increase in average selling price.
Cellulose Commodities Adjusted EBITDA Negative $3 million compared to negative $10 million in the prior year quarter. The improvement reflects higher selling prices and lower fixed costs.
Paperboard Net Sales $39 million, down $16 million or 29% compared to the prior year. The decline was driven by lower sales volumes and pricing from tariff uncertainty and competitive EU imports.
Paperboard Adjusted EBITDA $1 million compared to $11 million in Q3 of 2024, with margins of 3% compared to 20% in the prior year. The decline was due to lower sales and higher fixed costs.
High-Yield Pulp Net Sales $24 million, down $4 million or 14% compared to the prior year quarter. The decline was due to weaker demand and oversupply in China.
High-Yield Pulp Adjusted EBITDA Negative $9 million compared to positive $1 million in Q3 of 2024, with margins of negative 38% compared to 4% last year. The decline was due to lower sales and higher fixed costs.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Dissolving wood pulp fluff product: Developing a new product to avoid China tariffs, with technical team refining production to reduce costs.
New freezer board grade: Qualified and launched in Q3, with orders being secured.
Rolled softwood high-yield pulp: Qualification trials advancing with potential customers.
Oil and grease resistant board: Trials to begin this quarter.
High-yield pulp wrapper product: In testing phase, expected to deliver cost savings and new market entry in 2026.
Tariff impacts: 0 tariffs on Cellulose Specialties and dissolving wood pulp products into China, U.S. sales to the EU, and Canadian imports into the U.S. However, 10% tariff on fluff products into China remains a challenge.
Trade investigations: U.S. ITC's preliminary affirmative injury determination on Brazilian and Norwegian dissolving pulp imports, with preliminary duty determinations expected in early 2026.
Market conditions: Industry capacity utilization over 90%, with no major capacity additions expected before 2029. RYAM holds most of the excess Cellulose Specialty capacity.
Operational challenges: Stabilized challenges at Tartas, including French national strikes. Key technical roles filled since June.
Temiscaming site: Plan to return to profitability through cost reductions, operational improvements, and new product development. Active negotiations with U.S. customers affected by tariffs.
Cost reduction initiatives: $30 million reduction program for 2026 nearly implemented, with additional $20 million in cost improvements targeted for 2027.
Biomaterials projects: Progress on Altamaha Green Energy, BioNova Fernandina Beach bioethanol project, U.S. BioNova CTO project, and European BioNova CTO tolling project. Pre-biotics project redesigned for scalability.
EBITDA growth plan: Targeting over $300 million EBITDA by 2027 through pricing resets, cost reductions, and specialty commodity sales mix improvements.
Temiscaming divestiture: Restoring profitability and cash flow to divest the site at fair value post-USMCA free trade review in 2026.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Adjusted EBITDA Guidance Reduction: The full-year adjusted EBITDA guidance was reduced from $150-$160 million to $135-$140 million due to weaker paperboard markets, proactive downtime, and increased market weakness.
Fluff Business Challenges: The U.S. fluff industry faces increased competition in non-China markets due to China's 10% tariffs on U.S. fluff exports, creating headwinds for the business.
Operational Challenges at Tartas: Operational challenges at Tartas, including French national strikes and understaffing in key technical roles, have adversely affected operations.
Temiscaming Site Losses: The Temiscaming site is expected to incur an EBITDA loss of $14 million in 2025 due to lower paperboard prices, volumes, and planned downtime.
Paperboard Market Weakness: Lower sales volumes and pricing in the paperboard segment are driven by tariff uncertainty, competitive EU imports, and new U.S. capacity.
High-Yield Pulp Oversupply: The high-yield pulp segment faces oversupply in China, weaker demand, and shipment delays, leading to financial losses.
Working Capital and Cash Flow Pressures: Negative free cash flow year-to-date of $83 million is driven by working capital timing issues, which are expected to improve in Q4.
Debt and Leverage Concerns: The company has a net secured leverage ratio of 4.1x, close to the 5x covenant threshold, indicating financial pressure.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Full year adjusted EBITDA guidance: Refined to $135 million to $140 million, down from the prior $150 million to $160 million range, due to proactive downtime in noncore paperboard and high-yield pulp production and weaker paperboard markets.
Temiscaming site profitability: Plan to return to historical profitability by 2026 through cost reductions, operational improvements, new product development, and strategic negotiations. EBITDA loss of $14 million expected in 2025, with improvements projected for 2026 and 2027.
2027 EBITDA target: Plan to increase EBITDA to over $300 million by 2027 through pricing resets, cost reductions, and strategic capital projects.
Cellulose Specialties pricing: Significant price reset planned for 2026 to reflect product value and recapture inflation-driven cost increases.
Biomaterials projects: Several projects underway, including renewable power, bioethanol, CTO production, and pre-biotics, expected to generate high returns and profitable growth through 2028-2029.
Trade conditions: Trade conditions are expected to improve by 2026, with ongoing antidumping and countervailing duty investigations into Brazilian and Norwegian dissolving pulp imports.
Cost reduction initiatives: $30 million reduction program for 2026 nearly complete, with an additional $20 million in cost reductions targeted for 2027.
Biomaterials portfolio: Projects like Altamaha Green Energy and BioNova Fernandina Beach bioethanol expected to generate significant ROI and EBITDA contributions.
Market fundamentals for Cellulose Specialties: Industry capacity utilization over 90% with no major capacity additions expected before 2029, supporting pricing and margin improvements.
Temiscaming divestiture: Planned divestiture after restoring profitability and completing the USMCA free trade review by July 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What specific operational and financial milestones need to be achieved in 2026 to make the Paperboard and High-Yield Pulp assets viable for sale?
A:The milestones include the renewal of the USMCA agreement by July 2026, achieving positive EBITDA and cash flow, cost reductions, improved OEE of the paperboard plant, and successful commercialization of new products by Q1 and Q2 of 2026.
Q:How is the company thinking about refinancing and repricing opportunities considering the debt is callable in 2026?
A:The company plans to demonstrate a return to historical EBITDA levels, targeting $200 million LTM EBITDA, which will improve leverage and allow for refinancing. They aim to reduce interest costs significantly.
Q:What is the impact of a 1% increase in pricing over cost inflation for Cellulose Specialties?
A:A 1% increase in pricing generates $8-9 million in EBITDA. Since 2014, inflation has outpaced pricing by 35%, resulting in a $300 million value loss. The company plans to increase pricing significantly above inflation to recapture this value.
Q:What is the magnitude of working capital release expected from the decision to shut down operations temporarily?
A:The company expects a $14 million working capital release over the year, with a $10 million EBITDA loss due to the shutdown.
Q:What is the status of the AGE project and its potential impact?
A:The AGE project is progressing, with financing being the main hurdle. The project has a potential $650 million market cap impact, with $50 million EBITDA annually. The company needs $46 million in equity to finalize funding.
Q:What is the expected benefit from converting Temiscaming volumes to other facilities?
A:The company expects a $5 million EBITDA benefit in 2026 from converting volumes to other facilities. Additional conversions may occur, but some business has been lost to competitors.
Q:What caused the significant drop in paperboard realizations quarter-on-quarter?
A:The management did not provide a specific answer and deferred the question for further investigation.
Q:What is the status of the new fluff product that avoids Chinese tariffs?
A:The product has been developed and qualifies as dissolving wood pulp to avoid tariffs. However, its production cost is currently higher than the 10% tariff, so the company is working on reducing costs.
Q:What are the major buckets for the additional $20 million in EBITDA improvement projects through 2027?
A:The projects focus on improving reliability, material usage, automation, and predictive maintenance. These are similar to past initiatives.
Q:What caused the shipment delays to India in the High-Yield Pulp business, and will there be a catch-up?
A:The delays were due to limited ocean lane capacity between Montreal and India. The shipments are expected to catch up in Q4.
Q:Review of Unclear Management Responses
A:Management avoided providing a specific answer to the question about the significant drop in paperboard realizations quarter-on-quarter, deferring it for further investigation.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
BioNova CTO
Cellulose Specialties
Cellulose Specialty
China tariff
EU
MOU
Marcus
Paperboard line
RYAM Cellulose
RYAM asset
RYAM equity
Slide
Specialty capacity
Specialty product
Tartas
Temiscaming
additive
air permit
application
asset base
determination
diligence
duty
equity market
feed
multiple
position
product China
product value
progress
project RYAM
reset
ton
trial
upside
utility
valuation
year
yield pulp
RYAM Transcript
Rayonier Advanced Materials Inc. (RYAM) Q1 2026 Earnings Call Transcript
Positive5-6
The earnings call summary reveals strong financial performance, with revenue, gross margin, net income, and operating cash flow all showing significant year-over-year increases. This indicates effective cost management and operational efficiencies. Despite the lack of discussion on strategic initiatives and risks, the financial metrics alone suggest a positive sentiment. The absence of negative insights from the Q&A further supports this view. Given these factors, the stock price is likely to experience a positive movement in the next two weeks.
Rayonier Advanced Materials Inc. (RYAM) Q4 2025 Earnings Call Transcript
Unknown3-4
The earnings call presents a mixed outlook: while there are plans for substantial EBITDA improvement and price increases, guidance has been lowered, and there are challenges in the cellulose market. The Q&A reveals optimism from management but lacks clarity on key issues, such as rejected offers and trade duties impact. No new partnerships or strong financial metrics were highlighted, and the guidance cut may weigh on sentiment. Thus, the stock is likely to remain neutral over the next two weeks.
Rayonier Advanced Materials Inc. (RYAM) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call presents a mixed picture. While there are positive aspects like improved margins in Cellulose Specialties and cost reduction initiatives, challenges such as reduced EBITDA guidance, significant declines in Paperboard and High-Yield Pulp EBITDA, and unresolved issues in the Q&A session weigh heavily. The market is likely to react negatively due to the lowered 2025 guidance, operational challenges, and uncertainty in key business areas, despite some optimistic long-term projections.
Rayonier Advanced Materials Inc. (RYAM) Q2 2025 Earnings Conference Call Transcript
Unknown8-6
The earnings call reveals declining financial metrics, including a significant operating loss and reduced revenues across all segments, exacerbated by tariffs and operational challenges. The Q&A section highlights uncertainties in timelines and unclear management responses, which may further concern investors. Despite some positive elements like potential tariff benefits and future product commercialization, the immediate outlook is bleak, especially with reduced EBITDA guidance and negative cash flow. These factors suggest a negative stock price reaction over the next two weeks.
RYAM Slides
RYAM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
